[HTML][HTML] Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies
L Qi, AE Teschendorff - Clinical Epigenetics, 2022 - Springer
Most studies aiming to identify epigenetic biomarkers do so from complex tissues that are
composed of many different cell-types. By definition, these cell-types vary substantially in …
composed of many different cell-types. By definition, these cell-types vary substantially in …
Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies
L Qi, AE Teschendorff - Clinical epigenetics, 2022 - pubmed.ncbi.nlm.nih.gov
Most studies aiming to identify epigenetic biomarkers do so from complex tissues that are
composed of many different cell-types. By definition, these cell-types vary substantially in …
composed of many different cell-types. By definition, these cell-types vary substantially in …
[HTML][HTML] Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies
L Qi, AE Teschendorff - Clinical Epigenetics, 2022 - clinicalepigeneticsjournal …
Most studies aiming to identify epigenetic biomarkers do so from complex tissues that are
composed of many different cell-types. By definition, these cell-types vary substantially in …
composed of many different cell-types. By definition, these cell-types vary substantially in …
Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies.
L Qi, AE Teschendorff - Clinical Epigenetics, 2022 - go.gale.com
Most studies aiming to identify epigenetic biomarkers do so from complex tissues that are
composed of many different cell-types. By definition, these cell-types vary substantially in …
composed of many different cell-types. By definition, these cell-types vary substantially in …
[HTML][HTML] Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies
L Qi, AE Teschendorff - Clinical Epigenetics, 2022 - ncbi.nlm.nih.gov
Most studies aiming to identify epigenetic biomarkers do so from complex tissues that are
composed of many different cell-types. By definition, these cell-types vary substantially in …
composed of many different cell-types. By definition, these cell-types vary substantially in …
Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies.
L Qi, AE Teschendorff - Clinical Epigenetics, 2022 - search.ebscohost.com
Most studies aiming to identify epigenetic biomarkers do so from complex tissues that are
composed of many different cell-types. By definition, these cell-types vary substantially in …
composed of many different cell-types. By definition, these cell-types vary substantially in …
Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies.
L Qi, AE Teschendorff - Clinical Epigenetics, 2022 - europepmc.org
Most studies aiming to identify epigenetic biomarkers do so from complex tissues that are
composed of many different cell-types. By definition, these cell-types vary substantially in …
composed of many different cell-types. By definition, these cell-types vary substantially in …
[PDF][PDF] Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies
L Qi, AE Teschendorff - 2022 - clinicalepigeneticsjournal …
Most studies aiming to identify epigenetic biomarkers do so from complex tissues that are
composed of many different cell-types. By definition, these cell-types vary substantially in …
composed of many different cell-types. By definition, these cell-types vary substantially in …
Cell-type heterogeneity: Why we should adjust for it in epigenome and biomarker studies.
L Qi, AE Teschendorff - Clinical Epigenetics, 2022 - europepmc.org
Most studies aiming to identify epigenetic biomarkers do so from complex tissues that are
composed of many different cell-types. By definition, these cell-types vary substantially in …
composed of many different cell-types. By definition, these cell-types vary substantially in …